TITLE

Generation of conditional knockout alleles for PRL-3

AUTHOR(S)
Yan, Hong; Kong, Dong; Ge, Xiaomei; Gao, Xiang; Han, Xiao
PUB. DATE
November 2011
SOURCE
Journal of Biomedical Research;Nov2011, Vol. 25 Issue 6, p438
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Abstract: Phosphatase of regenerating liver-3 (PRL-3) is a member of the protein tyrosine phosphatase (PTP) superfamily and is highly expressed in cancer metastases. For better understanding of the role of PRL-3 in tumor metastasis, we applied a rapid and efficient method for generating PRL-3 floxed mice and investigated its phenotypes. A BAC retrieval strategy was applied to construct the PRL-3 conditional gene-targeting vector. Exon 4 was selected for deletion to generate a nonfunctional prematurely terminated short peptide as it will cause a frame-shift mutation. Conditional knockout PRL-3 mice were generated by using the Cre-loxP system and were validated by Southern blot and RT-PCR analysis. Further analysis revealed the phenotype characteristics of PRL-3 knockout mice and wildtype mice. In this study, we successfully constructed the PRL-3 conditional knockout mice, which will be helpful to clarify the roles of PRL-3 and the mechanisms in tumor metastasis.
ACCESSION #
70159129

 

Related Articles

  • Immunology: Csk keeps LYP on a leash. Zhong, Ming-Chao; Veillette, André // Nature Chemical Biology;May2012, Vol. 8 Issue 5, p412 

    The article presents a study by T. Vang and colleagues which assesses the inactivity of human lymphoid tyrosine phosphatase (LYP) when bound to C-terminal Src kinase (Csk) and activity when released. The study used mice as laboratory model, R620W mutation, and statistical analysis. Results show...

  • PTP4A3 (PRL-3) expression correlate with lymphatic metastases in gastric cancer. Pryczynicz, Anna; Guzińska-Ustymowicz, Katarzyna; Chang, Xiao-Jia; Kiśluk, Joanna; Kemona, Andrzej // Folia Histochemica et Cytobiologica;2010, Vol. 48 Issue 4, p632 

    Many studies have proved that protein tyrosine phosphatase type IVAmember 3 (PTP4A3, PRL-3) plays a major role in the metastasis of gastric cancer, especially to local lymph nodes. The objective of the current study was to assess the expression of PTP4A3 in gastric cancer in correlation with...

  • Activating Mutations in Protein Tyrosine Phosphatase Ptpn11 (Shp2) Enhance Reactive Oxygen Species Production That Contributes to Myeloproliferative Disorder Xu, Dan; Zheng, Hong; Yu, Wen-Mei; Qu, Cheng-Kui // PLoS ONE;May2013, Vol. 8 Issue 5, p1 

    Gain of function (GOF) mutations in protein tyrosine phosphatase Ptpn11 have been identified in childhood leukemias, and these mutations are sufficient to drive the development of myeloproliferative disorder and malignant leukemias in mice. However, the molecular mechanisms by which Ptpn11...

  • Regulation of mouse podocyte process dynamics by protein tyrosine phosphatases. Reiser, Jochen; Pixley, Fiona J.; Hug, Andreas; Kriz, Wilhelm; Smoyer, William E.; Stanley, E. Richard; Mundel, Peter // Kidney International;May2000, Vol. 57 Issue 5, p2035 

    Regulation of mouse podocyte process dynamics by protein tyrosine phosphatases. Rapid Communication. Background. Effacement of podocyte foot processes occurs early in many glomerular diseases associated with proteinuria and is accompanied by a reorganization of the actin cytoskeleton. The...

  • A critical role for the protein tyrosine phosphatase receptor type Z in functional recovery from demyelinating lesions. Harroch, Sheila; Furtado, Glaucia C.; Brueck, Wolfgang; Rosenbluth, Jack; Lafaille, Juan; Chao, Moses; Buxbaum, Joseph D.; Schlessinger, Joseph // Nature Genetics;Nov2002, Vol. 32 Issue 3, p411 

    Several lines of evidence suggest that tyrosine phosphorylation is a key element in myelin formation, differentiation of oligodendrocytes and Schwann cells, and recovery from demyelinating lesions[SUP1-7]. Multiple sclerosis is a demyelinating disease of the human central nervous system, and...

  • Tyrosine phosphatase SHP2 promotes breast cancer progression and maintains tumor-initiating cells via activation of key transcription factors and a positive feedback signaling loop. Aceto, Nicola; Sausgruber, Nina; Brinkhaus, Heike; Gaidatzis, Dimos; Martiny-Baron, Georg; Mazzarol, Giovanni; Confalonieri, Stefano; Quarto, Micaela; Hu, Guang; Balwierz, Piotr J; Pachkov, Mikhail; Elledge, Stephen J; van Nimwegen, Erik; Stadler, Michael B; Bentires-Alj, Mohamed // Nature Medicine;Apr2012, Vol. 18 Issue 4, p529 

    New cancer therapies are likely to arise from an in-depth understanding of the signaling networks influencing tumor initiation, progression and metastasis. We show a fundamental role for Src-homology 2 domain-containing phosphatase 2 (SHP2) in these processes in human epidermal growth factor...

  • RIP1-driven autoinflammation targets IL-1α independently of inflammasomes and RIP3. Lukens, John R.; Vogel, Peter; Johnson, Gordon R.; Kelliher, Michelle A.; Iwakura, Yoichiro; Lamkanfi, Mohamed; Kanneganti, Thirumala-Devi // Nature;6/13/2013, Vol. 498 Issue 7453, p224 

    The protein-tyrosine phosphatase SHP-1 has critical roles in immune signalling, but how mutations in SHP-1 cause inflammatory disease in humans remains poorly defined. Mice homozygous for the Tyr208Asn amino acid substitution in the carboxy terminus of SHP-1 (referred to as Ptpn6spin mice)...

  • RAS signaling pathway mutations and hypertrophic cardiomyopathy: getting into and out of the thick of it. Gelb, Bruce D.; Tartaglia, Marco // Journal of Clinical Investigation;Mar2011, Vol. 121 Issue 3, p844 

    In this issue of the JCI, Wu et al. and Marin et al. describe two new mouse models of inherited disorders of the RAS/MAPK signal transduction pathway that display hypertrophic cardiomyopathy (HCM); the model from the former paper was from a gain-of-function Raf1 mutation, and the model from the...

  • Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Tartaglia, Marco; Mehler, Ernest L.; Goldberg, Rosalie; Zampino, Giuseppe; Brunner, Han G.; Kremer, Hannie; van der Burgt, Ineke; Crosby, Andrew H.; Ion, Andra; Jeffery, Steve; Kalidas, Kamini; Patton, Michael A.; Kucherlapati, Raju S.; Gelb, Bruce D. // Nature Genetics;Dec2001, Vol. 29 Issue 4, p465 

    Noonan syndrome (MIM 163950) is an autosomal dominant disorder characterized by dysmorphic facial features, proportionate short stature and heart disease (most commonly pulmonic stenosis and hypertrophic cardiomyopathy). Webbed neck, chest deformity, cryptorchidism, mental retardation and...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics